![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SEQUENT.png)
Share the post "Sequent Scientific ‘s Q3 2024-25 Latest News: Profit Drops by 39.33% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 18.66 % in the past year, substantial increase in net sales/revenue by 6.01 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -24.02 %, Marginal increase in other income during this quarter, up by 2810.53%. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Sequent Scientific Limited. Profit dropped by -39.3 % Year to Year, Sequent Scientific Limited’s profitability increased by 2.21 % in this quarter. 🔹 EPS over the Year and quarter: EPS declined by -57.58 % Year to Year. EPS increased by 40 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 329.359 Cr | Rs. 368.65 Cr | Rs. 390.81 Cr | + 6.01 % | + 18.66 % |
| Expenses | Rs. 307.11 Cr | Rs. 329.55 Cr | Rs. 356.31 Cr | + 8.12 % | + 16.02 % |
| Operating Profit | Rs. 22.25 Cr | Rs. 39.1 Cr | Rs. 34.5 Cr | -11.76 % | + 55.06 % |
| OPM % | 6.76 % | 10.61 % | 8.83 % | -1.78 % | + 2.07 % |
| Other Income | Rs. 7.278 Cr | Rs. 0.19 Cr | Rs. 5.53 Cr | + 2810.53 % | -24.02 % |
| Interest | Rs. 12.58 Cr | Rs. 14.29 Cr | Rs. 14.95 Cr | + 4.62 % | + 18.84 % |
| Depreciation | Rs. 15.46 Cr | Rs. 17.1 Cr | Rs. 16.98 Cr | -0.7 % | + 9.83 % |
| Profit before tax | Rs. 1.49 Cr | Rs. 7.9 Cr | Rs. 8.1 Cr | + 2.53 % | + 443.62 % |
| Tax % | 616.03 % | 19.75 % | 20 % | + 0.25 % | -596.03 % |
| Net Profit | Rs. 10.68 Cr | Rs. 6.34 Cr | Rs. 6.48 Cr | + 2.21 % | -39.33 % |
| EPS in Rs | Rs. 0.33 | Rs. 0.1 | Rs. 0.13 | + 30 % | -60.61 % |
Today, we’re looking at Sequent Scientific Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 18.66 %. However, it did see a marginal increase of 6.01 % from the previous quarter. Expenses ticked up slightly by 8.12 % quarter-on-quarter, aligning with the annual rise of 16.02 %. Operating profit, while up 55.06 % compared to last year, faced a quarter-on-quarter dip of -11.76 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.07 %, but a shrinkage of -1.78 % sequentially. Other income rose by 2810.53 % compared to the last quarter, despite an annual decline of -24.02 %. Interest expenses surged remarkably by 4.62 % from the previous quarter, yet the year-over-year increase remains at a moderate 18.84 %. Depreciation costs fell by -0.7 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 9.83 %. Profit before tax grew annually by 443.62 % but saw an increase from the preceding quarter by 2.53 %.
Tax expenses as a percentage of profits decreased slightly by -596.03 % compared to last year, with a more notable quarter-on-quarter increase of 0.25 %. Net profit fell by -39.33 % year-on-year but experienced a 2.21 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -60.61 % but a quarterly rise of 30 %. In summary, Sequent Scientific Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 329.359 Cr | Rs. 368.65 Cr | Rs. 390.81 Cr | + 6.01 % | + 18.66 % |
| Expenses | Rs. 307.11 Cr | Rs. 329.55 Cr | Rs. 356.31 Cr | + 8.12 % | + 16.02 % |
| Operating Profit | Rs. 22.25 Cr | Rs. 39.1 Cr | Rs. 34.5 Cr | -11.76 % | + 55.06 % |
| Net Profit | Rs. 10.68 Cr | Rs. 6.34 Cr | Rs. 6.48 Cr | + 2.21 % | -39.33 % |
| EPS in Rs | Rs. 0.33 | Rs. 0.1 | Rs. 0.13 | + 30 % | -60.61 % |
In reviewing Sequent Scientific Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 18.66 % year-on-year growth, however, there was a minor increase of 6.01 % from the previous quarter. Expenses rose by 16.02 % compared to the previous year, with a 8.12 % increase quarter-on-quarter. Operating Profit surged by 55.06 % annually, and saw a -11.76 % decrease from the last quarter.
Net Profit showed yearly decrease of -39.33 %, and experienced a 2.21 % increase from the previous quarter. Earnings Per Share (EPS) fell by -60.61 % annually, however rose by 30 % compared to the last quarter. In essence, while Sequent Scientific Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
